DRI Healthcare Trust News

DRI Healthcare Trust Downgraded to Hold as CEO Fired Amid an Investigation; Price Target Cut to C$15.00

MT NewswiresJul 9 09:52 ET

RBC Capital Reiterates Outperform on DRI HEALTHCARE TRUST, Maintains C$20 Price Target

BenzingaJul 3 09:10 ET

National Bank Highlights Key Takeaways From DRI Healthcare Trust's Investor Meetings; Raises Price Target

MT NewswiresDec 22, 2023 13:07 ET

RBC Capital Reiterates Outperform on DRI HEALTHCARE TRUST, Maintains C$18 Price Target

BenzingaNov 28, 2023 10:24 ET

DRI Healthcare Trust Maintains Buy Rating From Stifel GMP as It Adds a New Drug Royalty; Price Target Kept at C$20.00

MT NewswiresJul 10, 2023 09:39 ET

RBC Capital Maintains Outperform on DRI Healthcare Trust, Raises Price Target to C$18

BenzingaJul 10, 2023 08:28 ET

DRI Healthcare Trust Price Target Raised to $18 at Raymond James

MT NewswiresJul 4, 2023 08:06 ET

DRI Healthcare Trust Initiated at Buy at Stifel GMP; Price Target Set at C$20.00

MT NewswiresJun 9, 2023 09:26 ET

Truist Securities Maintains Buy on DRI Healthcare Trust, Raises Price Target to C$14

BenzingaMay 26, 2023 09:53 ET

RBC Capital Maintains Outperform on DRI Healthcare Trust, Raises Price Target to C$17

BenzingaApr 28, 2023 12:01 ET

Raymond James Initiates Coverage On DRI Healthcare Trust With Outperform Rating, Announces Price Target of C$13.5

BenzingaApr 5, 2023 09:03 ET

Raymond James Initiates Coverage On DRI Healthcare Trust With Outperform Rating, Announces Price Target of C$13.5

BenzingaApr 4, 2023 09:27 ET

RBC Capital Maintains Outperform on DRI Healthcare Trust, Raises Price Target to C$16

BenzingaMar 10, 2023 09:02 ET

UBS Initiates Coverage On DRI Healthcare Trust with Buy Rating, Announces Price Target of C$10

Benzinga Real-time NewsJun 14, 2022 04:58 ET